In recent years a considerable amount of data have been produced on the activity of the microsomal drug metabolizing Systems in the human fetus [10, 16, 17, 18, 19, 21, 26, 29, 32] . They all indicate that the various metabolic Systems responsible for drug degradation are already present in the intrauterine life, though their specific activity is in most cases considerably lower than that of adult Standards. "In vitro" data, while certainly necessary, do not provide an exact index of the rate of "in vivo" metabolism and therefore the Information which can be derived is not easily applicable to clinical Problems. In fact drug effects are also determined by other factors, such äs absorption rate, plasma protein binding, tissue distribution and excretion rate. All these factors vary both with age and physiopathological Status [21, 26] . For this reason studies and observations on newborn infants provide further useful Information, which can eventually be applied to everyday practice. Most of the data currently available on drug kinetics and metabolism in the newborn infant concern antibiotic and sulfonamide compounds [8, 11, 23, 24, 26, 27, 28] though some observations have also been carried out with other drugs [13, 14, 21, 22, 30, 31] . In most cases they indicate a slower disposition of the drug äs compared to children. No data on the metabolic disposition of benzodiazepines in the newborn infant have been available up to now, despite the fact that this class of drug is widely administered during gestation and labor [3, 15] , and in the first days of extrauterine life to control seizures [20] . In the present report we will describe some observations we were able to make on premature infants, full-term infants and children who received diazepam for therapeutic reasons. In adult subjects diazepam undergoes metabolic demethylation, and hydroxylation, and it is excreted mainly äs conjugated derivatives [2, 4, 6, 25] . Evidence will be presented that in premature infants äs well äs in full-term newborns there is a reduced capability to hydroxylate diazepam 
Blood sampling and urine collection
From 4 prematures and 4 children it was possible to collect heparinized venous blood samples (l-1.5 ml) at various times before and after administration (Tab. I). Fractionated 24 hour urine samples were collected whenever possible in all the three groups (premature infants, fullterm infants and children). Blood samples were centrifuged within 30 minutes and the plasma so obtained kept frozen at 20°C until analyzed for benzodiazepine content. Similarly samples of urine were frozen after collection and kept at 20°C until analyzed.
Chemical analysis
Determination of diazepam (DZ), N-demethyldiazepam (NDZ) and oxazepam (OX) was carried out on 0.2-0.4 ml of plasma and on 5-10 ml of urine according to GARATTINI et al. [5] with some modifications as described below.
Extraction from plasma
0.2-0.4 ml of plasma buffered with l ml of phosphate buffer (pH 7) was extracted three times with 4ml of diethyl ether. 10 ml of the organic combined fraction was then back-extracted with 3 ml of l N HCL The äcqueous phase was washed twice with 5 ml of diethyl ether and alkalinized to pH 9-10 with 0.7 ml of 6 N NaOH. The alkalinized äcqueous fraction was then extracted three times with 5 ml of diethyl ether and 14 ml of the organic phase was dried out in a water-bath at 40°C in a finely tapered test tube. The drug residue was then redissolved in 50 \ of acetone containing 2-N-benzylamino-5-chloro-benzophenone (5 //g/ml) as internal marker, l-2 of 'ttiis solution was used for GLC determination.
Extraction from urine
5 ml of urine was bufiered with 3 ml of phosphate buffer (pH 7) and extracted three times with 5 ml of diethyl ether. 12 ml of the organic phase were then processed as described for plasma, and the remaining äcqueous phase used for determination of conjugated compounds.
Extraction of conjugated compounds from urine
After extraction with ether at pH 7, the äcqueous phase was. acidified to pH 5 with 0.5 ml of 6 N HC1 and 2.5 ml of acetate buffer (pH 5) and incubated overnight at 37°C with 5 10 3 units of /?-glucuronidase. The urine was then alkalinized to pH 9-10 with 6 N NaOH and extracted three times with 5 ml of diethyl ether. 14 ml of the organic phase were then dried and processed as before. Determinations of N-Methyloxazepam (MeOX) were performed on 0.1 ml of plasma and 5 ml of urine according to the recently described procedure of BELVEDERE et al.
[1]. This procedure is based on the conversion of NMethyloxazepam to its TMS derivative and leads to· improved suisitivity. The identity of the compounds was. checked by TLC (CH Cl 3 -Acetone 9:1) and by combined gaschromatography-mass-spectrometry against known reference Standards.
Apparatus
A CARLO ERB A Fractovap Model G l, gaschromatographê quipped with 63 Mi ECD was used. Diazepam, N-demethyldiazepam and oxazepam determinations were performed on a glass column 2 m long, 4 mm i. d., packed with 3% O V 17 on Gaschrom Q (Applied Science Lab.) operated at the following temperatures: oven 270°C, injector 280°C, detector 285°C. Carrier gasflow (Nitrogen) 40 ml/min.; scavenger gas flow (Nitrogen)' 70 ml/min. N-Methyloxazepam determinations were carried. out on a glass column l m long, 4 mm i. d., packed as. before and operated at the following temperatures: oven 220°C, injector 240°C, detector 250°C. Carrier and scavenger gas flow 50 ml/min. An LKB 9000 gaschromatographmass-spectrometer was used for mass analysis.
Statistical analysis
Owing to the small number o£ blood samples taken, it was not possible to calculate individuaL kinetics for the data in Tab. I. However, a regression analysis on the logarithms o£ the combined diazepam plasma concentrations showed that the means at 8, 12, 24 and 48 hours could be considered to be linearly related for both premature infants and children. The slope of the regression line, is proportional to the average pharmacokinetic elimination constant, Kel. This Kel may be considered as the "body elimination rate" (GIBALDI et al. [7] ) and is related to the apparent body half life of the drug, T 1^; the volumeof distribution (Vd) wascalculated according to GIB ALDI et al. [7] , A Student's t-test was used to test the significance of the difference between the slopes o£ the two regression lines. The results o£ this significance test extend to cover differences between the body elimination rates and the apparent body half lives. Comparisons between means score was made using Student's t-test.
Results

Plasma levels of diazepam and of its metabolites in premature infants and children
As mentioned above in "methods" we were able to follow up individual plasma levels of The premature group showed a Kel of 0.013 with an apparent plasma half-life of 54 hours, while the children had a Kel of 0.038 and an apparent plasma half-life of 18 hours (P < 0.05 for this difference). Diffqqences were also present in the volume of distribution. With regard to the diazepam metabolites no Nmethyloxazepam or oxazepam could be detected in plasma of either group. N-demethyldiazepam, on the contrary, was f ound in measurable amounts both in prematures and children. Even so, appreciable differences were observed. While in all the four children studied N-demethyl diazepam was already present in measurable amounts l hour after drug administration, in the premature infants the compound was measurable only after 8 hours in 3 out of 4 cases. These data suggest a slower demethylation process in premature infants. It is also interesting that while for the children in 3 out of 4 cases the N-demethyldiazepäm levels tended to decline after 24 hours, for the premature group in 3 out of 4 cases the N-demethyldiazepam levels were still increasing after 48 hours. These data suggest a reduced breakdown of the demethylated metabolite.
24-hour urinary excretion of diazepam and of its metabolites in premature infants and children
The 24-hour urinary excretion of diazepam and its metabolites was followed up in The total amount of benzodiazepine excreted äs conjugated compounds in the first 24 hour s following drug administration was higher in children than in full-term infants (P < 0.05) or in premature infants (P < 0.01). This picture becomes more interesting when we consider the single metabolic products and their ratios. In fact, äs reported in Tab. V, although N-demethyldiazepam was present in equivalent amounts in all the groups, marked difFerences were observed with regard to the hydroxylated metabolites (N-methyloxazepam and oxazepam). In the premature group no hydroxylated compounds were detectable even in the 81 day-old subject (case 9). In the full-term group, hydroxylated compounds were absent or present in unmeasurable amounts up to 10 days of age, while they were constantly present in subjects over 2-3 weeks of age. However, mean values were lower when compared to the children (Fig. 1) . The difference was more marked for oxazepam than for N-methyloxazepam. If we consider the ratios between the hydroxylated derivatives and the non-hydroxylated ones, we can see (Tab. VI) that only in the 5 month-old infant is the ratio of the same magnitude s that observed in fully grown children.
Discussion
After administration of a single pro kilo dose of the drug, premature infants tended to have higher and more persistent plasma levels of diazepam in comparison to the children. The apparent plasma disappearance rate was significantly prolonged in the premature group suggesting a reduced capability of the processes responsible for molecule breakdown and elimination. Other factors may however play an important role in determining this phenomenon.
Diazepam is kiiown to accumulate in considerable amounts in the adipose tissue of animals and humans [6, 12] . A different binding of diazepam to various tissue components or a reduced amount of adipose tissue could in part explain the higher levels of diazepam observed in premature infants. In fact a considerable difference in distribution of volume was observed in our cases. The rate of formation of N-demethyldiazepam was slower in prematures than in children suggesting that the total capacity of the demethylating System is comparatively reduced in the first group. Furthermore that the tendency to accumulate Ndemethyldiazepam with high »levels persists even after 48 hours suggests that hydroxylation processes are likewise inefficient in the premature. This hypothesis is further sustained • by the urinary data. No hydroxylated compounds could in fact be detected in the urine of premature infants and the same was observed in full-term infants less than two weeks old. The total conjugated benzodiazepines present in the 24 hour urine were also lower in premature and f ll term infants than in children. Other authors [9, 21] have described the presence of hydroxylated compounds in the urine of newborns after drug administration to the mother.r However no attempt was really made to clarify whether the hydroxylated compounds were derived from the mother or were inherent in the newborn metabolism.
A reduced drug metabolizing activity in the premature and newborn is further supported by preliminary observations [26] in which diazepam and its metabolites were followed up in newborns whose mothers had been exposed to benzodiazepine treatment before the delivery. It was seen that both diazepam and N-demethyldiafcepam crossed the placenta and both accumulated in the fetus. The plasma concentrations of diazepam and N-demethyldiazepam were quite constant during the first 48-72 hours of extra-uterine life, suggesting a reduced capacity in the newborn to further metabolize the drugs.
In conclusion it appears from our data that newborn infants, both premature and füll term, have a limited capacity for metabolizing and excreting drugs. It also seems likely that the degree of limitation of the various drug Summary Benzodiazepines are often used during labor, and they are also frequently administered to newborns in cases of seizure. In adults this class of drug requires an extensive metabolization in order to be eliminated. The physiological elimination of diazepam administered at the dose of 0.3 mg/kg by intramuscular route (Tab. I), was followed up in three groups of subjects {premature infants, full-term infants and children). Plasma levels of diazepam (DZ) and of its major metabolite N-demethyldiazepam (NDZ) could be followed up for 48 hours after drug administration in 4 premature infants and 4 children. 24 hour urinary excretion of DZ, NDZ, N-Methyloxazepam (MeOX) and Oxazepam (OX) was followed up in 7 premature infants, 8 füll term infants and 5 children. Determination of benzodiazepine compounds both in plasma and urine, was performed, after etheral extraction, by GLC-ECD. In the urine samples free and cönjugated compounds were measured (Tab. HD. The apparent disappearance rate of diazepam plasma was significantly reduced (P < 0.05) in premature infants (T x / 2 = 58 hrs) when compared to that of the children metabolizing Systems is not uniform, and different results may also be obtained with other Substrates. From a practical point of view, a limited metabolizing and excreting activity implies a longer persistence of pharmacologically active substances in the neonatal body fluids and tissues, and consequently prolonged pharmacological effects. The clinical implications of this phenomenon are almost completely unknown. Although our findings cannot establish the optimal dosage regimen of diazepam, they suggest that the drug should be used in premature and füll term infants at lower doses than in children. More data are needed on the metabolism of drugs in newborns and infants äs the necessary premise to a more integrated approach, both pharmacological and clinical, to the problem of drug dosage in newborn infants.
The rate of formation of N-demethyldiazepam was slower in prematures than in children.
A difference in the distribution of volume was also noticed. The urinary data further supported reduced DZ elimination in the premature infants and fullterm infants. No hydroxylated derivatives (MeOX and OX) were in fact found in the urine of premature infants nor in the urine of full-term infants up of 10 days of age. On the contrary the hydroxylated compounds (MeOX and OX) represented the major portion of diazepam metabolites present in the urine of children. The data indicate that in the newborn (either premature or füll term) the physiological elimination of diazepam is markedly reduced when compared to children. This is probably du? to a limited capacity to form Ndemethylated and hydroxylated derivatives which are subsequently excreted äs such or äs cönjugated compounds. A prolonged persistence of diazepam and of its Ndemethylderivative (which still retains pnarmacological activity) in the biological fluids and tissues has to be taken into account when this drug is administered to newborns. when compared to that of the children = 18 hrs). Keywords: Diazepam, physiological elimination, metabolism, premature infants, füll term infants, children, plasma levels, urinary excrstion. 
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